/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Fibrobiologics Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$0.26 -0.0312(-3.12%) FBLG at 04 Dec 2025 04:31 PM Biotechnology
Lowest Today 0.241
Highest Today 0.2539
Today’s Open 0.2518
Prev. Close 0.2632
52 Week High 2.55
52 Week Low 0.24
Day’s Range: Low 0.241 High 0.2539
52-Week Range: Low 0.24 High 2.55
1 day return -
1 Week return -7.29
1 month return -23.6
3 month return -56.83
6 month return -70.26
1 year return -89.55
3 year return -
5 year return -
10 year return -

Institutional Holdings

Market Status

Strong Buy: 1

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 16.13 M

PB Ratio 134.353

PE Ratio 0.0

Enterprise Value 19.04 M

Total Assets 16.45 M

Volume 1689399

Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M

Annual Profit FY25:-573000 -0.6M, FY24:-437000 -0.4M, FY23:null 0.0M

Annual Net worth FY25:-11161000 -11.2M, FY24:-16485000 -16.5M, FY23:-5121000 -5.1M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-231000 -0.2M, Q2/2025:-206000 -0.2M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:-140000 -0.1M

Quarterly Net worth Q3/2025:-5778000 -5.8M, Q2/2025:-4658000 -4.7M, Q1/2025:-4966000 -5.0M, Q3/2024:-500000 -0.5M, Q2/2024:898000 0.9M

Fund house & investment objective

Company Information FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.

Organisation Biotechnology

Employees 13

Industry Biotechnology

CEO Mr. Peter O'Heeron

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow